Investor Relations

CHF Solutions is an early stage company focused on commercializing the Aquadex FlexFlow® system. Our objective is to improve the quality of life for patients with heart failure and related conditions, such as fluid overload. CHF Solutions is listed on the NASDAQ Capital Market.

Press Releases

Posted on Nov 30, 2017
EDEN PRAIRIE, Minn., Nov. 30, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today that Claudia Drayton, Chief Financial Officer will be a featured presenter at the LD Micro 10th Annual Main Event on Tuesday, December 5, 2017 at 9:30 AM Pacific Time. The conference is being h...

Read More

Posted on Nov 27, 2017
EDEN PRAIRIE, Minn., Nov. 27, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today the closing of an underwritten public offering of Series F convertible preferred stock, together with warrants, for gross proceeds of $18.0 million, prior to deducting underwriting discounts an...

Read More

Posted on Nov 22, 2017
EDEN PRAIRIE, Minn., Nov. 22, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today the pricing of an underwritten public offering of Series F convertible preferred stock, together with warrants, for gross proceeds of $18.0 million, prior to deducting underwriting discounts an...

Read More

Events & Presentations